|
2025-02-14 |
2025-02-14 |
S
Sale
|
Spaventa Andrew
Chief Executive Officer
Executive Director
|
800
-35.8%
19.89
USD 15,912
|
800
-35.8%
|
19.89
|
USD 15,912
|
|
|
2024-12-17 |
2024-12-16 |
S
Sale
|
Spaventa Andrew
Chief Executive Officer
Executive Director
|
180
-22.2%
20.16
USD 3,629
|
180
-22.2%
|
20.16
|
USD 3,629
|
|
|
2024-11-13 |
2024-11-12 |
S
Sale
|
Spaventa Andrew
Chief Executive Officer
Executive Director
|
695
-31.1%
22.55
USD 15,669
|
695
-31.1%
|
22.55
|
USD 15,669
|
|
|
2024-09-18 |
2024-09-18 |
B
Purchase
|
TANG KEVIN
Large shareholder
|
32,000
+9.4%
17.21
USD 550,720
|
32,000
+9.4%
|
17.21
|
USD 550,720
|
|
|
2024-09-18 |
2024-09-17 |
B
Purchase
|
TANG KEVIN
Large shareholder
|
40,000
+13.3%
15.33
USD 613,200
|
40,000
+13.3%
|
15.33
|
USD 613,200
|
|
|
2024-09-18 |
2024-09-16 |
B
Purchase
|
TANG KEVIN
Large shareholder
|
50,416
+20.2%
12.74
USD 642,300
|
50,416
+20.2%
|
12.74
|
USD 642,300
|
|
|
2024-09-17 |
2024-09-15 |
S
Sale
|
Spaventa Andrew
Chief Executive Officer
Executive Director
|
175
-21.6%
12.38
USD 2,167
|
175
-21.6%
|
12.38
|
USD 2,167
|
|
|
2023-11-20 |
2023-11-17 |
B
Purchase
|
Spaventa Andrew
Chief Executive Officer
Executive Director
|
75,000
+1.9%
0.42
USD 31,755
|
75,000
+1.9%
|
0.42
|
USD 31,755
|
|
|
2023-11-20 |
2023-11-16 |
B
Purchase
|
Spaventa Andrew
Chief Executive Officer
Executive Director
|
43,468
+1.1%
0.41
USD 17,857
|
43,468
+1.1%
|
0.41
|
USD 17,857
|
|
|
2023-11-20 |
2023-11-16 |
B
Purchase
|
Glezer Eli N.
Chief Scientific Officer
Officer
|
200,000
+4.6%
0.43
USD 85,640
|
200,000
+4.6%
|
0.43
|
USD 85,640
|
|
|
2023-08-15 |
2023-08-15 |
S
Sale
|
Kamdar Kim P.
Non-Executive Director
|
200,000
-5.0%
0.53
USD 106,960
|
200,000
-5.0%
|
0.53
|
USD 106,960
|
|
|
2023-08-15 |
2023-08-14 |
S
Sale
|
Kamdar Kim P.
Non-Executive Director
|
77,991
-1.9%
0.57
USD 44,424
|
77,991
-1.9%
|
0.57
|
USD 44,424
|
|
|
2023-08-15 |
2023-08-11 |
S
Sale
|
Kamdar Kim P.
Non-Executive Director
|
353,657
-8.0%
0.60
USD 210,603
|
353,657
-8.0%
|
0.60
|
USD 210,603
|
|
|
2023-05-18 |
2023-05-17 |
B
Purchase
|
Glezer Eli N.
Chief Scientific Officer
Officer
|
170,000
+4.1%
0.82
USD 138,924
|
170,000
+4.1%
|
0.82
|
USD 138,924
|
|
|
2022-12-13 |
2022-12-12 |
B
Purchase
|
Glezer Eli N.
Chief Scientific Officer
Officer
|
50,000
+1.2%
2.00
USD 100,000
|
50,000
+1.2%
|
2.00
|
USD 100,000
|
|
|
2022-05-19 |
2022-05-18 |
B
Purchase
|
Pellini Michael J
Non-Executive Director
|
26,834
+37.0%
3.30
USD 88,552
|
26,834
+37.0%
|
3.30
|
USD 88,552
|
|
